Retrospective Study
Copyright ©The Author(s) 2022.
World J Gastrointest Surg. Nov 27, 2022; 14(11): 1230-1249
Published online Nov 27, 2022. doi: 10.4240/wjgs.v14.i11.1230
Table 4 Chi-square analysis of the number of removed lymph nodes and patient characteristics in the pT1-pT4 subgroups in the Surveillance, Epidemiology, and End Results validation cohort
Characteristics
pT1 (2746), RLNs
P value
pT2 (1534), RLNs
P value
pT3 (4570), RLNs
P value
pT4 (2304), RLNs
P value
≤ 12
13-24
≥ 25
≤ 17
18-30
≥ 31
≤ 19
20-38
≥ 39
≤ 16
17-44
≥ 45
Sex0.5210.2630.0330.668
Male7276782885843051211988101222357663082
Female4284391863161387077546910344851157
Age (yr)0.0180.0490.0060.054
≤ 602783051452521336486949913030638453
> 60877810329648410127189498219671875786
Tumor location0.0080.001< 0.001< 0.001
Upper third3543821403481685413917099315914313
Middle third134139819359391881465410917234
Lower third66759625345921698118462617975682692
Tumor size (mm)0.5750.009< 0.0010.002
≤ 50966934387695314132158174914944341746
> 501891838720512959118243217758172493
Histological type0.6480.9450.9510.193
Well-moderately differentiated538502217304138677824278616914725
Poorly-undifferentiated31631414130415862121262814439746952
Signet ring cell1871936412358264062285123828837
Others1141085216989363631984522023725
pN stage< 0.001< 0.001< 0.001< 0.001
pN010088853695472559611965269425316616
pN11151485321691396642754823613519
pN228633010652315613115529821221
pN34212231452534236912923762883
pTNM< 0.001< 0.001< 0.001< 0.001
I1123103342254725596000000
II32824632214370186080114218013013
III0263145259036801848441011126